Former Pre-Seed Funding Company Receives Venture Capitol Investment

Tangent Medical Technologies, a recipient of Pre-Seed Capital Funding in 2010 through Ann Arbor SPARK, has recently secured 4.5 million in venture capital to bring their product to market. This funding will accelerate the commercialization of Tangent’s medical device, the NovaCath™, which is designed to replace the intravenous drug systems that are currently used in hospitals. Tangent’s history with SPARK dates back to 2009, when they participated... [Read More...]

SPARK Central incubator tenant Hygieia, Inc. receives 510(k) clearance from FDA

Hygieia, Inc., a tenant at the SPARK Central business incubator, recently received official 510(k) clearance from the US Food and Drug Administration (FDA) for its BaseSens I Blood Glucose Monitoring System.  Hygieia, Inc. is a start‐up that is developing a proprietary hybrid medical device that combines state‐of‐the‐art blood glucose monitoring capability with a physician‐initiated self‐adjusting insulin dose calculator. Of the news,... [Read More...]